Literature DB >> 19001092

Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin.

Yoshihide Asano1, Margaret Markiewicz, Masahide Kubo, Gabor Szalai, Dennis K Watson, Maria Trojanowska.   

Abstract

Biosynthesis of fibrillar collagen in the skin is precisely regulated to maintain proper tissue homeostasis; however, the molecular mechanisms involved in this process remain largely unknown. Transcription factor Fli1 has been shown to repress collagen synthesis in cultured dermal fibroblasts. This study investigated the role of Fli1 in regulation of collagen biosynthesis in mice skin in vivo using mice with the homozygous deletion of the C-terminal transcriptional activation (CTA) domain of the Fli1 gene (Fli1(DeltaCTA/DeltaCTA)). Skin analyses of the Fli1 mutant mice revealed a significant upregulation of fibrillar collagen genes at mRNA level, as well as increased collagen content as measured by acetic acid extraction and hydroxyproline assays. In addition, collagen fibrils contained ultrastructural abnormalities including immature thin fibrils and very thick irregularly shaped fibrils, which correlated with the reduced levels of decorin, fibromodulin, and lumican. Fibroblasts cultured from the skin of Fli1(DeltaCTA/DeltaCTA) mice maintained elevated synthesis of collagen mRNA and protein. Additional experiments in cultured fibroblasts have revealed that although Fli1 DeltaCTA retains the ability to bind to the collagen promoter in vitro and in vivo, it no longer functions as transcriptional repressor. Together, these results establish Fli1 as a key regulator of the collagen homeostasis in the skin in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001092      PMCID: PMC2612518          DOI: 10.1128/MCB.01278-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway.

Authors:  J Czuwara-Ladykowska; F Shirasaki; P Jackers; D K Watson; M Trojanowska
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

Review 2.  Factors involved in the regulation of type I collagen gene expression: implication in fibrosis.

Authors:  Asish K Ghosh
Journal:  Exp Biol Med (Maywood)       Date:  2002-05

Review 3.  Molecular biology of the Ets family of transcription factors.

Authors:  Tsuneyuki Oikawa; Toshiyuki Yamada
Journal:  Gene       Date:  2003-01-16       Impact factor: 3.688

4.  The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1.

Authors:  A Arvand; S M Welford; M A Teitell; C T Denny
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

Review 5.  Immunopathogenesis of scleroderma--evolving concepts.

Authors:  A N Sapadin; A C Esser; R Fleischmajer
Journal:  Mt Sinai J Med       Date:  2001 Sep-Oct

Review 6.  Molecular aspects of scleroderma.

Authors:  Maria Trojanowska
Journal:  Front Biosci       Date:  2002-03-01

Review 7.  The role of decorin in collagen fibrillogenesis and skin homeostasis.

Authors:  Charles C Reed; Renato V Iozzo
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

8.  Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.

Authors:  Apollina Goel; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

9.  Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

Authors:  Masahide Kubo; Joanna Czuwara-Ladykowska; Omar Moussa; Margaret Markiewicz; Edwin Smith; Richard M Silver; Stefania Jablonska; Maria Blaszczyk; Dennis K Watson; Maria Trojanowska
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

Review 10.  Building collagen molecules, fibrils, and suprafibrillar structures.

Authors:  David J S Hulmes
Journal:  J Struct Biol       Date:  2002 Jan-Feb       Impact factor: 2.867

View more
  32 in total

1.  Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1.

Authors:  Omar Moussa; Amanda C LaRue; Romeo S Abangan; Christopher R Williams; Xian K Zhang; Masahiro Masuya; Yong Z Gong; Demetri D Spyropoulos; Makio Ogawa; Gary Gilkeson; Dennis K Watson
Journal:  Mol Cell Biol       Date:  2010-09-07       Impact factor: 4.272

Review 2.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.

Authors:  Yoshihide Asano; Andreea M Bujor; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2010-07-03       Impact factor: 4.563

Review 3.  Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.

Authors:  Maria Trojanowska
Journal:  Nat Rev Rheumatol       Date:  2010-06-29       Impact factor: 20.543

Review 4.  Update on macrophages and innate immunity in scleroderma.

Authors:  Jennifer J Chia; Theresa T Lu
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

Review 5.  Fibrogenesis, novel lessons from animal models.

Authors:  Ellen De Langhe; Rik Lories
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

Review 6.  Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.

Authors:  Kazuyuki Tsujino; Dean Sheppard
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

7.  Global Gene Expression Analysis in PKCα-/- Mouse Skin Reveals Structural Changes in the Dermis and Defective Wound Granulation Tissue.

Authors:  Nichola H Cooper; Jeya P Balachandra; Matthew J Hardman
Journal:  J Invest Dermatol       Date:  2015-09-09       Impact factor: 8.551

8.  Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.

Authors:  Takashi Taniguchi; Yoshihide Asano; Kaname Akamata; Shinji Noda; Takehiro Takahashi; Yohei Ichimura; Tetsuo Toyama; Maria Trojanowska; Shinichi Sato
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

Review 9.  Animal models of scleroderma: current state and recent development.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

Review 10.  Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.

Authors:  Maria Trojanowska
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.